Re: Now that we're a small cap stock....
in response to
by
posted on
Jul 12, 2018 01:10PM
This is for oncology but there are similar kninds of "rules of thumb" for other non-revenue biotechs coming into phase 3 results.
Over 300 million market cap is good!